Osara Health

We introduce employer healthcare innovations to the world

What’s the issue?

• Cancer is the #1 driver of employer healthcare spend and is expected to rise another 30% over the next 5 years

• Over 40% of Americans diagnosed with cancer go bankrupt within 3 years, often driven by costly, unplanned hospital visits

• 45% of people diagnosed with cancer in the United States are working age, 40% of which never return to work

Introducing

What they do

Osara Health is a digital care platform that uses behavioral health coaching to improve return-to-work outcomes for employees with cancer:

• Osara Health has demonstrated an 8.2X ROI, savings of >$11K per patient, and 91% utilization (!!!) across mid-market and jumbo employers

• Currently, Osara Health has 54 enterprise and government clients, including Coca-Cola, IBM, and AllState Benefits

How they do it

• Dedicated health coaches and digital educational modules to support employees through their cancer journey and caregivers helping loved ones with cancer

• Training for human resources, support staff, and leadership to create an environment truly supportive of people with cancer

• Helps employers save money by mitigating avoidable hospital visits and improving return to work success metrics

Who they are

• Founders:

  • Raghav Murali-Ganesh: CEO and Co-Founder, Former Radiation Oncologist

  • Tim Atkins: COO and Co-Founder

• Headquarters: Eveleigh, Australia (recently expanded to U.S.)

• Employee Count: 39

Who else is out there?

• Jasper: Backed by General Catalyst, Human Capital, W Health Ventures, Redesign Health, and 7wireVentures

• Thyme Care: Backed by Echo Health Ventures, CVS Ventures, Town Hall Ventures, Foresite Capital, Andreesen Horowitz, AlleyCorp, Casdin Capital, and Frist Cressey Ventures

Our thoughts

SUCCESS DRIVERS

• Hair on fire problem: According to Business Group on Health, cancer is for the second year in a row the #1 driver of high cost claims for self-funded employers, who anticipate these costs rising by another 30% over the next 5 years

• Excellent metrics: Impressive ROI and utilization metrics enable a cleaner, easier sell to self-funded employers

• Existing traction: Experience with large enterprise and government employers should enable more rapid adoption within the U.S., despite recent entry into the market

POTENTIAL ISSUES

• Competition: Rapid growth of cancer-focused solutions may crowd out Osara Health as a newer U.S. entrant

• Hesitancy to overstep: Employers may express concern with overstepping clinician-patient relationships

• Narrow focus: Employers fatigued by point solutions may express resistance to contracting directly with Osara Health given its relatively narrow focus, preferring instead to contract with solution providers that deliver a more comprehensive oncology solution

Your thoughts

Here’s what you thought about our last featured startup, Leap Health: